1. Chalcones Repressed the AURKA and MDR Proteins Involved in Metastasis and Multiple Drug Resistance in Breast Cancer Cell Lines
    Tatiana Komoto et al, 2018, Molecules CrossRef
  2. Licochalcone A Protects the Blood–Milk Barrier Integrity and Relieves the Inflammatory Response in LPS-Induced Mastitis
    Wenjin Guo et al, 2019, Front. Immunol. CrossRef
  3. Licochalcone A Inhibits Cellular Motility by Suppressing E-cadherin and MAPK Signaling in Breast Cancer
    Wen-Chung Huang et al, 2019, Cells CrossRef
  4. Licochalcone A Inhibits BDNF and TrkB Gene Expression and Hypoxic Growth of Human Tumor Cell Lines
    Michitsune Arita et al, 2020, IJMS CrossRef
  5. Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
    Amit S. Choudhari et al, 2020, Front. Pharmacol. CrossRef
  6. Unlocking the Potential of HK2 in Cancer Metabolism and Therapeutics.
    Sara N Garcia et al, 2019, Curr Med Chem CrossRef
  7. Antiproliferative Effect of Acridine Chalcone Is Mediated by Induction of Oxidative Stress
    Peter Takac et al, 2020, Biomolecules CrossRef
  8. Licochalcone A Selectively Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs
    Chung-Pu Wu et al, 2020, J. Nat. Prod. CrossRef
  9. Licochalcone a Induces ROS-Mediated Apoptosis through TrxR1 Inactivation in Colorectal Cancer Cells.
    Peng Wu et al, 2020, Biomed Res Int CrossRef
  10. LncRNA-BLACAT1 Facilitates Proliferation, Migration and Aerobic Glycolysis of Pancreatic Cancer Cells by Repressing CDKN1C via EZH2-Induced H3K27me3
    Xin Zhou et al, 2020, Front. Oncol. CrossRef
  11. Flavonoids Targeting HIF-1: Implications on Cancer Metabolism.
    Marek Samec et al, 2021, Cancers (Basel) CrossRef
  12. The Newly Synthetized Chalcone L1 Is Involved in the Cell Growth Inhibition, Induction of Apoptosis and Suppression of Epithelial-to-Mesenchymal Transition of HeLa Cells
    Tomas Kuruc et al, 2021, Molecules CrossRef
  13. Potential of Bioactive Food Components against Gastric Cancer: Insights into Molecular Mechanism and Therapeutic Targets
    Seog Young Kang et al, 2021, Cancers CrossRef
  14. Pharmacological Effects and Underlying Mechanisms of Licorice-Derived Flavonoids
    Yufan Wu et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
  15. Licochalcone A Promotes the Ubiquitination of c-Met to Abrogate Gefitinib Resistance
    Shuangze Han et al, 2022, BioMed Research International CrossRef
  16. Exploiting the Metabolic Consequences of PTEN Loss and Akt/Hexokinase 2 Hyperactivation in Prostate Cancer: A New Role for δ-Tocotrienol
    Fabrizio Fontana et al, 2022, IJMS CrossRef
  17. Phytochemicals as Regulators of Tumor Glycolysis and Hypoxia Signaling Pathways: Evidence from In Vitro Studies
    Ioana-Ecaterina Pralea et al, 2022, Pharmaceuticals CrossRef
  18. Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies.
    Yi Zhang et al, 2022, Cancers (Basel) CrossRef
  19. Correlation of Glucose Metabolism with Cancer and Intervention with Traditional Chinese Medicine
    Gui-hua Lai et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
  20. Natural products targeting glycolytic signaling pathways-an updated review on anti-cancer therapy
    Yuting Cui et al, 2022, Front. Pharmacol. CrossRef
  21. Natural compounds targeting glycolysis as promising therapeutics for gastric cancer: A review
    Maoyuan Zhao et al, 2022, Front. Pharmacol. CrossRef
  22. A new strategy for osteoarthritis therapy: Inhibition of glycolysis
    Chunmei Tan et al, 2022, Front. Pharmacol. CrossRef
  23. Traditional Chinese medicine for transformation of gastric precancerous lesions to gastric cancer: A critical review
    Yi-Lin Zhong et al, 2023, World J Gastrointest Oncol CrossRef
  24. Anticancer effects of licochalcones: A review of the mechanisms
    Nan Deng et al, 2023, Front. Pharmacol. CrossRef
  25. Xiaojianzhong decoction prevents gastric precancerous lesions in rats by inhibiting autophagy and glycolysis in gastric mucosal cells
    Jia-Xiang Zhang et al, 2023, World J Gastrointest Oncol CrossRef
  26. Integrated bioinformatics and network pharmacology identifying the mechanisms and molecular targets of Guipi Decoction for treatment of comorbidity with depression and gastrointestinal disorders
    Menglin Liu et al, 2023, Metab Brain Dis CrossRef
  27. Licochalcone A inhibits EGFR signalling and translationally suppresses survivin expression in human cancer cells.
    Feng Gao et al, 2021, J Cell Mol Med CrossRef
  28. Licochalcone A: a review of its pharmacology activities and molecular mechanisms
    Meihua Liu et al, 2024, Front. Pharmacol. CrossRef
  29. Biological insights and therapeutic potential of Glycyrrhiza uralensis and its bioactive compounds: an updated review
    Sibhghatulla Shaikh et al, 2024, Arch. Pharm. Res. CrossRef